2nd Priority Review Voucher Summit 2017

The 2nd Priority Review Voucher Summit 2017 is dedicated to the regulatory landscape, valuation approaches, benefits and challenges of developing a drug that would be eligible for a Priority Review Voucher.

The 2nd Priority Review Voucher Summit 2017 covers topics such as:

• The changing regulatory landscape and the future of the program
• The various priority review voucher programs and their respective eligibility requirements
• The challenges of clinical study design , operational logistics and patient engagement for developing rare disease therapeutics
• The various valuation models to utilize before buying or selling a priority review voucher
• Regulatory requirements - composing and submitting compliant documentation

The 2nd Priority Review Voucher Summit 2017 brings together attendees from pharmaceutical companies, social enterprises, patient groups, government agencies and the investment community.